GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Recessive Dystrophic Epidermolysis Bullosa
Related studies linked through entity extraction aliases.
A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa
- Status
- RECRUITING
- Phase
- PHASE3
Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Pilot Study to Evaluate a Temporary Skin Substitute (Spincare® Matrix) for Wound Healing in RDEB Patients
- Status
- COMPLETED
- Phase
- NA
A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)
- Status
- COMPLETED
- Phase
- PHASE2
Long-Term Follow-up Protocol
- Status
- RECRUITING
- Phase
- N/A
A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa
- Status
- COMPLETED
- Phase
- PHASE3
A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB
- Status
- COMPLETED
- Phase
- PHASE3
Molecular Signatures of Cutaneous Squamous Cell Carcinoma During Recessive Dystrophic Epidermolysis Bullosa
- Status
- UNKNOWN
- Phase
- N/A
Phase 3, Open-label Clinical Trial of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2